Lv4
600 积分 2024-08-12 加入
Aldosterone synthase inhibitors in hypertension and chronic kidney disease: double the benefit?
22天前
已关闭
Aldosterone–mineralocorticoid receptor interactions: new insights and therapeutic perspectives in primary aldosteronism
26天前
已完结
New drug therapies for hypertension
29天前
已完结
Second-Generation Aldosterone Synthase Inhibitors for Hypertension
29天前
已完结
Effect of baxdrostat on ambulatory blood pressure in patients with resistant hypertension (Bax24): a phase 3, randomised, double-blind, placebo-controlled trial
29天前
已完结
Efficacy and Safety of Aldosterone Synthase Inhibitors in Primary Hypertension: An Updated Meta-analysis of Randomized Controlled Trials
29天前
已完结
Aldosterone synthase inhibitors in hypertension and chronic kidney disease: double the benefit?
29天前
已关闭
Pulmonary Hypertension Associated With Left Heart Disease: Challenges, Emerging Strategies, and Future Directions
1个月前
已完结
Pulmonary Hypertension Associated with Left Heart Disease
1个月前
已关闭
Renal Tubular Handling of Glucose and Fructose in Health and Disease
1个月前
已完结
皖公网安备34019202002308
